Journal
TRENDS IN MOLECULAR MEDICINE
Volume 23, Issue 10, Pages 899-916Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2017.08.001
Keywords
-
Funding
- Intramural Research Program of the National Institute on Aging
- NIA intra-laboratory grant
- HELSE SOR-OST RHF [2017056]
- Research Council of Norway [262175]
- Oticon Foundation
- Ib Henriksen's Foundation
- Her Majesty Queen Margrethe II's Travel Grant
- Velux Foundation
Ask authors/readers for more resources
The coenzyme NAD(+) is critical in cellular bioenergetics and adaptive stress responses. Its depletion has emerged as a fundamental feature of aging that may predispose to a wide range of chronic diseases. Maintenance of NAD(+) levels is important for cells with high energy demands and for proficient neuronal function. NAD(+) depletion is detected in major neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, cardiovascular disease and muscle atrophy. Emerging evidence suggests that NAD(+) decrements occur in various tissues during aging, and that physiological and pharmacological interventions bolstering cellular NAD(+) levels might retard aspects of aging and forestall some age-related diseases. Here, we discuss aspects of NAD(+) biosynthesis, together with putative mechanisms of NAD(+) action against aging, including recent preclinical and clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available